Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$32.76 - $39.56 $7,174 - $8,663
-219 Reduced 6.51%
3,143 $109,000
Q4 2023

Feb 15, 2024

SELL
$14.5 - $38.0 $4,582 - $12,008
-316 Reduced 8.59%
3,362 $127,000
Q3 2023

Nov 07, 2023

SELL
$15.75 - $26.31 $5,764 - $9,629
-366 Reduced 9.05%
3,678 $67,000
Q2 2023

Aug 14, 2023

BUY
$16.96 - $27.82 $10,277 - $16,858
606 Added 17.63%
4,044 $104,000
Q1 2023

May 15, 2023

SELL
$18.45 - $27.14 $24,409 - $35,906
-1,323 Reduced 27.79%
3,438 $64,000
Q4 2022

Feb 14, 2023

SELL
$20.18 - $33.33 $151,390 - $250,041
-7,502 Reduced 61.18%
4,761 $117,000
Q3 2022

Nov 14, 2022

BUY
$11.58 - $24.73 $1,053 - $2,250
91 Added 0.75%
12,263 $220,000
Q2 2022

Aug 12, 2022

BUY
$8.52 - $25.26 $69,898 - $207,233
8,204 Added 206.75%
12,172 $138,000
Q1 2022

May 16, 2022

SELL
$19.89 - $43.18 $4,614 - $10,017
-232 Reduced 5.52%
3,968 $88,000
Q4 2021

Feb 14, 2022

SELL
$26.75 - $46.02 $120,241 - $206,859
-4,495 Reduced 51.7%
4,200 $183,000
Q3 2021

Nov 15, 2021

SELL
$25.18 - $37.81 $11,532 - $17,316
-458 Reduced 5.0%
8,695 $290,000
Q2 2021

Aug 10, 2021

BUY
$14.69 - $27.52 $27,690 - $51,875
1,885 Added 25.94%
9,153 $252,000
Q1 2021

May 17, 2021

BUY
$16.27 - $41.26 $2,196 - $5,570
135 Added 1.89%
7,268 $146,000
Q4 2020

Feb 12, 2021

BUY
$15.96 - $50.0 $113,842 - $356,650
7,133 New
7,133 $235,000

Others Institutions Holding INBX

# of Institutions
1
Shares Held
18.6K
Call Options Held
0
Put Options Held
0

About Inhibrx, Inc.


  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $570M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.